Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WISE: Letrozole for Breast Cancer Prevention
NCT00090857Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Feb 2002
- Primary completion
- Aug 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in breast cancer comparing Letrozole with Placebo (2 arms). Primary endpoints: Change in Lumbar Density From Baseline to 12 Months, Change in Femoral Neck Density From Baseline to 12 Months and 2 more. Started Feb 2002; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00090857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090857.